R 0009/18 (Petition for review) of 11.02.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:R000918.20190211
- Date of decision
- 11 February 2019
- Case number
- R 0009/18
- Petition for review of
- -
- Application number
- 05012711.7
- IPC class
- A61P 19/10A61K 31/663A61P 19/08
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method of administering bisphosphonates
- Applicant name
- Novartis AG
Novartis Pharma GmbH - Opponent name
- Generics [UK] Limited
Sanovel IIaç San. ve Tic. A.S.
Taylor Wessing LLP - Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112a(2)(c)European Patent Convention Art 113(1)European Patent Convention R 106
- Keywords
- Petition for review (clearly not allowable)
Violation of Article 112a(2)(c) EPC (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The petition is unanimously rejected as clearly unallowable.